Adapted exercise is an effective non-pharmacological tool to improve functional,cognitive, and psychological parameters in multiple sclerosis (MS), in association withincreased quality of life (QoL) and decreased disease severity. Adipose tissue, throughthe production of different adipokines, is involved in regulating energy metabolism andinflammation. Adiponectin, increased in MS, circulates as oligomers of low (LMW),medium (MMW), and high molecular weight (HMW), the latter mediating the mainbiological effects. The aim of study was to evaluate the effects of 4 months trainingat moderate intensity [65% heart rate reserve (HRR)] on BMI, adiponectin, and QoL in avolunteer with secondary progressive MS. The parameters were evaluated before (T0),after 4 months training (T1), and 6 months after the end of training (T2); total serumadiponectin and its oligomeric profile were evaluated. We found a reduction in BMI(0.9%) and FAT (2.6%), an improvement in perceived QoL and a reduced expressionof total adiponectin and HMW oligomers together with decreased MS disability levelat T1 measured by EDSS. Despite the limitations of a case study, this represent astarting point to understand the influence of exercise in MS and the relationship withadiponectin expression.
Adapted exercise is an effective non-pharmacological tool to improve functional, cognitive, and psychological parameters in multiple sclerosis (MS), in association with increased quality of life (QoL) and decreased disease severity. Adipose tissue, through the production of different adipokines, is involved in regulating energy metabolism and inflammation. Adiponectin, increased in MS, circulates as oligomers of low (LMW), medium (MMW), and high molecular weight (HMW), the latter mediating the main biological effects. The aim of study was to evaluate the effects of 4 months training at moderate intensity [65% heart rate reserve (HRR)] on BMI, adiponectin, and QoL in a volunteer with secondary progressive MS. The parameters were evaluated before (T0), after 4 months training (T1), and 6 months after the end of training (T2); total serum adiponectin and its oligomeric profile were evaluated. We found a reduction in BMI (-0.9%) and FAT (-2.6%), an improvement in perceived QoL and a reduced expression of total adiponectin and HMW oligomers together with decreased MS disability level at T1 measured by EDSS. Despite the limitations of a case study, this represent a starting point to understand the influence of exercise in MS and the relationship with adiponectin expression.
Case Report: Concurrent Resistance and Aerobic Training Regulate Adiponectin Expression and Disease Severity in Multiple Sclerosis: A Case Study
Grazioli E;Cerulli C;Tranchita E;Parisi A;Buono P;
2020-01-01
Abstract
Adapted exercise is an effective non-pharmacological tool to improve functional,cognitive, and psychological parameters in multiple sclerosis (MS), in association withincreased quality of life (QoL) and decreased disease severity. Adipose tissue, throughthe production of different adipokines, is involved in regulating energy metabolism andinflammation. Adiponectin, increased in MS, circulates as oligomers of low (LMW),medium (MMW), and high molecular weight (HMW), the latter mediating the mainbiological effects. The aim of study was to evaluate the effects of 4 months trainingat moderate intensity [65% heart rate reserve (HRR)] on BMI, adiponectin, and QoL in avolunteer with secondary progressive MS. The parameters were evaluated before (T0),after 4 months training (T1), and 6 months after the end of training (T2); total serumadiponectin and its oligomeric profile were evaluated. We found a reduction in BMI(0.9%) and FAT (2.6%), an improvement in perceived QoL and a reduced expressionof total adiponectin and HMW oligomers together with decreased MS disability levelat T1 measured by EDSS. Despite the limitations of a case study, this represent astarting point to understand the influence of exercise in MS and the relationship withadiponectin expression.File | Dimensione | Formato | |
---|---|---|---|
Grazioli 2020 Frontiers in Neuroscience.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
658.8 kB
Formato
Adobe PDF
|
658.8 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.